-- The Sapphire device is the
first multi-therapy touch screen infusion pump available for use in
hospital, ambulatory and home care settings --
PARIS, March 13, 2013 /PRNewswire/ -- Hospira, Inc.
(NYSE: HSP), the world's leading provider of injectable drugs and
infusion technologies, today launched in Europe the multi-therapy Sapphire™ infusion
device at the 18th Congress of the European Association of Hospital
Pharmacists (EAHP).
The Sapphire device is a compact and lightweight infusion pump
for use in hospitals, home care and ambulatory settings. Device
features include the large, intuitive, colour touch-screen, which
is designed for easy and quick programming. The Sapphire device's
peristaltic pumping system incorporates magnetic flow-control
technology and provides low-flow continuity. The pump is designed
to deliver medication with a high rate of accuracy during
treatment, reduce energy consumption and extend battery life. It
includes infusion modes for all intended uses to simplify the
patient's care through various clinical areas.[1]
Hospira is launching the Sapphire device in Europe following the company's announcement of
an international distribution agreement for the product with Q Core
Medical, Ltd. in January. The agreement grants Hospira the right to
market and distribute the infusion pump in more than 60 markets.
The device is available immediately for order in France, Italy
and the UK, with availability in additional European markets to
follow. Hospira's leading position in infusion technologies
combined with the product strengths of the Sapphire device will
benefit infusion pump customers and patients alike.
"Adding the Sapphire system to the Hospira product portfolio
strengthens the breadth of the company's already comprehensive
medication management business and reflects the commitment of the
company to the devices business. It satisfies a wide range of
critical drug delivery needs in ambulatory, hospital and home care
environments and readily adapts to emerging needs," commented
Svend Andersen, president,
Europe, Middle East and Africa, Hospira. "The agreement to
market and distribute the Sapphire device extends Hospira's ability
to support patient safety in key geographies around the world."
EAHP congress attendees are invited to view demonstrations of
the Sapphire device at the Hospira stand, number 50 in the congress
plan.
About Hospira
Hospira, Inc. is the world's leading provider of injectable
drugs and infusion technologies. Through its broad, integrated
portfolio, Hospira is uniquely positioned to Advance Wellness™ by
improving patient and caregiver safety while reducing healthcare
costs. The company is headquartered in Lake Forest, Ill., and has approximately
16,000 employees. Learn more at www.hospira.com.
[1] Uses include Continuous, Intermittent, TPN, PCA, Multi-step,
Intermittent Epidural and PCEA Epidural.